183 related articles for article (PubMed ID: 18336980)
1. Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Lee EY; Spear BT; Glauert HP
Food Chem Toxicol; 2008 Jun; 46(6):2062-73. PubMed ID: 18336980
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Spear BT; Glauert HP
Toxicol Appl Pharmacol; 2004 Aug; 199(1):1-9. PubMed ID: 15289085
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate.
Tharappel JC; Nalca A; Owens AB; Ghabrial L; Konz EC; Glauert HP; Spear BT
Toxicol Sci; 2003 Oct; 75(2):300-8. PubMed ID: 12883078
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin E on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-κB after treatment with phenobarbital.
Li J; Harp C; Tharappel JC; Spear BT; Glauert HP
Food Chem Toxicol; 2011 Oct; 49(10):2706-9. PubMed ID: 21726593
[TBL] [Abstract][Full Text] [Related]
5. Effect of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF-kappaB.
Lu Z; Lee EY; Robertson LW; Glauert HP; Spear BT
Toxicol Sci; 2004 Sep; 81(1):35-42. PubMed ID: 15201435
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.
Li Y; Glauert HP; Spear BT
Biochem Pharmacol; 2000 Feb; 59(4):427-34. PubMed ID: 10644051
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
[TBL] [Abstract][Full Text] [Related]
8. Effect of phenobarbital on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-kappaB.
Tharappel JC; Spear BT; Glauert HP
Toxicol Appl Pharmacol; 2008 Feb; 226(3):338-44. PubMed ID: 17963809
[TBL] [Abstract][Full Text] [Related]
9. Effect of extracellular matrix on the expression of peroxisome proliferation associated genes in cultured rat hepatocytes.
Hong JT; Glauert HP
Toxicol In Vitro; 2000 Apr; 14(2):177-84. PubMed ID: 10793296
[TBL] [Abstract][Full Text] [Related]
10. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Nilakantan V; Spear BT; Glauert HP
Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats.
Leung LK; Glauert HP
Toxicology; 1997 Nov; 123(1-2):101-9. PubMed ID: 9347925
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes.
Hong JT; Glauert HP
Toxicology; 1998 Nov; 131(2-3):99-107. PubMed ID: 9928625
[TBL] [Abstract][Full Text] [Related]
14. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
Srinivasan SR; Chow CK; Glauert HP
Toxicology; 1990 Jun; 62(3):321-32. PubMed ID: 2389247
[TBL] [Abstract][Full Text] [Related]
15. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
Hong JT; Yun YP
Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418
[TBL] [Abstract][Full Text] [Related]
16. Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.
Glauert HP; Beaty MM; Clark TD; Greenwell WS; Tatum V; Chen LC; Borges T; Clark TL; Srinivasan SR; Chow CK
J Cancer Res Clin Oncol; 1990; 116(4):351-6. PubMed ID: 1975253
[TBL] [Abstract][Full Text] [Related]
17. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB.
Li Y; Tharappel JC; Cooper S; Glenn M; Glauert HP; Spear BT
DNA Cell Biol; 2000 Feb; 19(2):113-20. PubMed ID: 10701777
[TBL] [Abstract][Full Text] [Related]
18. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
20. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity.
Nilakantan V; Spear BT; Glauert HP
Free Radic Biol Med; 1998 Jun; 24(9):1430-6. PubMed ID: 9641260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
